Fred Lee

Fred is the Managing Director, Head of Business Origination at Revelation Partners.

With over 14 years of banking and investment experience, Fred focuses on identifying and reviewing new investment opportunities, as well as managing the firm’s industry relationships. Fred is responsible for sourcing recent investments in Adaptive Biotechnologies, Omada Health, NeuroPace, SomaLogic, and Synthego.

Prior to Revelation Partners, Fred was a Managing Director in the Life Sciences Group at Bridge Bank, where he executed venture debt investments across all healthcare sectors. Fred began his career in the Healthcare Investment Banking group at Citi, where he advised on a number of M&A and financing transactions for both public and private healthcare clients.

Fred received a BS in Business Administration and BA in Economics from the University of California, Berkeley.

When not working with healthcare companies and investors, Fred enjoys running, playing basketball, and snowboarding. He lives in Orinda, California, with his wife and two young children.